"I think it is also wise to remember that biomedical products are notoriously difficult to get through regulation and then become accepted best practice. The medical community is rightly cautious and slower to adopt innovation than most other markets. "
This has been my point all along.
strangelogic, what are your opinions on BTMs ability to penetrate the US market for the near future?
- Forums
- ASX - By Stock
- PNV
- Polynovo Channel 7
Polynovo Channel 7, page-30
-
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
|
|||||
Last
$2.58 |
Change
0.020(0.78%) |
Mkt cap ! $1.780B |
Open | High | Low | Value | Volume |
$2.61 | $2.63 | $2.56 | $2.465M | 952.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 10700 | $2.57 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.58 | 24502 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1356 | 2.560 |
3 | 14994 | 2.550 |
5 | 18736 | 2.540 |
2 | 3382 | 2.530 |
2 | 19162 | 2.520 |
Price($) | Vol. | No. |
---|---|---|
2.580 | 1698 | 1 |
2.590 | 2201 | 1 |
2.600 | 2201 | 1 |
2.610 | 2201 | 1 |
2.620 | 2201 | 1 |
Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |